Osborne Partners Capital Management, LLC Novartis Ag Transaction History

Osborne Partners Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 23, 2020	SELL	$80.93 - $91.1 $220,534 - $248,247	-2,725 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$84.35 - $95.37 $4,217 - $4,768	50 Added 1.87%	2,725 $258,000
Q2 2019 Jul 18, 2019	SELL	$75.4 - $92.8 $7,389 - $9,094	-98 Reduced 3.53%	2,675 $244,000
Q1 2019 Apr 24, 2019	BUY	$75.32 - $86.15 $208,862 - $238,893	2,773 New	2,773 $267,000
Q1 2018 Apr 19, 2018	SELL	$70.39 - $84.15 $269,241 - $321,873	-3,825 Closed	0 $0
Q4 2017 Jan 25, 2018	SELL	$72.33 - $77.64 $39,636 - $42,546	-548 Reduced 12.53%	3,825 $321,000
Q3 2017 Oct 19, 2017	BUY	$74.14 - $77.27 $324,214 - $337,901	4,373	4,373 $375,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Osborne Partners Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Osborne Partners Capital Management, LLC with notifications on news.